{"id":{"repo_id":"mtu","oai_identifier":"oai:digitalcommons.mtu.edu:etdr-3308"},"canonical_url":"https://search.ndltd.org/etd/mtu/oai:digitalcommons.mtu.edu:etdr-3308","repository":{"repo_id":"mtu","name":"Michigan Technological University","base_url":"https://digitalcommons.mtu.edu/do/oai/"},"display":{"title":"Exploring Fructose Mimetics as Chemotherapeutic Potentiators: Impact on GLUT5-Mediated Cancer Cell Vulnerability","abstract":"Metabolic reprogramming toward increased sugar uptake is a hallmark of cancer, and fructose-specific uptake through the facilitative transporter GLUT5 is selectively upregulated in several adenocarcinomas, including breast and lung cancer. This dissertation develops and characterizes a panel of fluorescent fructose mimetics – the coumarin-based ManCou probes and the quinolinone-based ManQuin probes – as GLUT5-targeted reporters, cytotoxic effectors, and chemosensitization adjuvants, and establishes the boundaries within which each role holds. The central experimental strategy pairs each GLUT5-targeted glycoconjugate with its sugar-free aglycone control, isolating transporter-mediated cytotoxicity from cytotoxicity intrinsic to the fluorophore itself. In luminal (MCF7) and triple-negative (MDA-MB-231) breast carcinoma, the GLUT5-targeted ManCou conjugates produce durable, phenotype-scaled cytotoxicity that exceeds and outlasts that of the matched aglycones, while relatively sparing normal fibroblasts and defining a therapeutic window. The transport-restricting conjugate ManCou-Ph and the quinoline ManQuin-5 additionally sensitize triple-negative lines to the DNA-damaging agents oxaliplatin and cyclophosphamide at sub-cytotoxic concentrations, with the benefit confined to the sub-saturating dose range of each chemotherapeutic. In A549 lung adenocarcinoma, this relationship inverts: the GLUT5-targeted conjugates are inert across the tested concentration range, while the sugar-free aglycones – particularly the unsubstituted coumarin – produce marked, time-dependent cytotoxicity. This dissociation, further tested using the differently-selective ManQuin probes, identifies a tissue-level boundary on the conjugate-driven mechanism rather than a failure of GLUT5 routing, and reframes A549 cytotoxicity as intrinsic to the fluorophore rather than transporter-mediated. Across all phenotypes, the ManQuin probes maintain low intrinsic cytotoxicity through 72 hours of continuous exposure and impose no latent or post-washout toxicity, validating their use as non-perturbing reporters of GLUT5 activity independent of their role as effectors elsewhere in the panel. Together, these results establish a matched aglycone-conjugate framework for isolating GLUT5-mediated effects from off-target fluorophore activity and demonstrate that a single probe scaffold can serve three distinct roles, reporter, effector, and chemosensitization adjuvant, with the operative role determined by cell-line phenotype and by which structural feature of the probe is engaged.","abstract_html":"Metabolic reprogramming toward increased sugar uptake is a hallmark of cancer, and fructose-specific uptake through the facilitative transporter GLUT5 is selectively upregulated in several adenocarcinomas, including breast and lung cancer. This dissertation develops and characterizes a panel of fluorescent fructose mimetics – the coumarin-based ManCou probes and the quinolinone-based ManQuin probes – as GLUT5-targeted reporters, cytotoxic effectors, and chemosensitization adjuvants, and establishes the boundaries within which each role holds. The central experimental strategy pairs each GLUT5-targeted glycoconjugate with its sugar-free aglycone control, isolating transporter-mediated cytotoxicity from cytotoxicity intrinsic to the fluorophore itself. In luminal (MCF7) and triple-negative (MDA-MB-231) breast carcinoma, the GLUT5-targeted ManCou conjugates produce durable, phenotype-scaled cytotoxicity that exceeds and outlasts that of the matched aglycones, while relatively sparing normal fibroblasts and defining a therapeutic window. The transport-restricting conjugate ManCou-Ph and the quinoline ManQuin-5 additionally sensitize triple-negative lines to the DNA-damaging agents oxaliplatin and cyclophosphamide at sub-cytotoxic concentrations, with the benefit confined to the sub-saturating dose range of each chemotherapeutic. In A549 lung adenocarcinoma, this relationship inverts: the GLUT5-targeted conjugates are inert across the tested concentration range, while the sugar-free aglycones – particularly the unsubstituted coumarin – produce marked, time-dependent cytotoxicity. This dissociation, further tested using the differently-selective ManQuin probes, identifies a tissue-level boundary on the conjugate-driven mechanism rather than a failure of GLUT5 routing, and reframes A549 cytotoxicity as intrinsic to the fluorophore rather than transporter-mediated. Across all phenotypes, the ManQuin probes maintain low intrinsic cytotoxicity through 72 hours of continuous exposure and impose no latent or post-washout toxicity, validating their use as non-perturbing reporters of GLUT5 activity independent of their role as effectors elsewhere in the panel. Together, these results establish a matched aglycone-conjugate framework for isolating GLUT5-mediated effects from off-target fluorophore activity and demonstrate that a single probe scaffold can serve three distinct roles, reporter, effector, and chemosensitization adjuvant, with the operative role determined by cell-line phenotype and by which structural feature of the probe is engaged.","abstract_has_math":false,"creators":["Buwa, Vedant"],"institution":null,"degree_name":"Doctor of Philosophy in Biochemistry and Molecular Biology (PhD)","degree_level":"Open Access Dissertation","degree_discipline":"Department of Chemistry","degree_department":null,"school":null,"contributors":["Marina Tanasova","Smitha Rao-Hatti"],"advisors":[],"committee_chairs":[],"committee_members":["Tarun Dam","Mark Tang","Robert Larson"],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:19:32Z","subjects":["Biochemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.mtu.edu/etdr/2130"],"render_values":[{"text":"https://digitalcommons.mtu.edu/etdr/2130","href":"https://digitalcommons.mtu.edu/etdr/2130","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.37099/mtu.dc.etdr/2130","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/10.37099/mtu.dc.etdr/2130","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.mtu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.mtu.edu%3Aetdr-3308","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Marina Tanasova","Smitha Rao-Hatti"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Tarun Dam","Mark Tang","Robert Larson"]},{"key":"dc:creator","label":"Author","values":["Buwa, Vedant"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.created","label":"Dc Date Created","values":["2026-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Department of Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Open Access Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy in Biochemistry and Molecular Biology (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biochemistry"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.37099/mtu.dc.etdr/2130","https://digitalcommons.mtu.edu/etdr/2130"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Metabolic reprogramming toward increased sugar uptake is a hallmark of cancer, and fructose-specific uptake through the facilitative transporter GLUT5 is selectively upregulated in several adenocarcinomas, including breast and lung cancer. This dissertation develops and characterizes a panel of fluorescent fructose mimetics – the coumarin-based ManCou probes and the quinolinone-based ManQuin probes – as GLUT5-targeted reporters, cytotoxic effectors, and chemosensitization adjuvants, and establishes the boundaries within which each role holds. The central experimental strategy pairs each GLUT5-targeted glycoconjugate with its sugar-free aglycone control, isolating transporter-mediated cytotoxicity from cytotoxicity intrinsic to the fluorophore itself. In luminal (MCF7) and triple-negative (MDA-MB-231) breast carcinoma, the GLUT5-targeted ManCou conjugates produce durable, phenotype-scaled cytotoxicity that exceeds and outlasts that of the matched aglycones, while relatively sparing normal fibroblasts and defining a therapeutic window. The transport-restricting conjugate ManCou-Ph and the quinoline ManQuin-5 additionally sensitize triple-negative lines to the DNA-damaging agents oxaliplatin and cyclophosphamide at sub-cytotoxic concentrations, with the benefit confined to the sub-saturating dose range of each chemotherapeutic. In A549 lung adenocarcinoma, this relationship inverts: the GLUT5-targeted conjugates are inert across the tested concentration range, while the sugar-free aglycones – particularly the unsubstituted coumarin – produce marked, time-dependent cytotoxicity. This dissociation, further tested using the differently-selective ManQuin probes, identifies a tissue-level boundary on the conjugate-driven mechanism rather than a failure of GLUT5 routing, and reframes A549 cytotoxicity as intrinsic to the fluorophore rather than transporter-mediated. Across all phenotypes, the ManQuin probes maintain low intrinsic cytotoxicity through 72 hours of continuous exposure and impose no latent or post-washout toxicity, validating their use as non-perturbing reporters of GLUT5 activity independent of their role as effectors elsewhere in the panel. Together, these results establish a matched aglycone-conjugate framework for isolating GLUT5-mediated effects from off-target fluorophore activity and demonstrate that a single probe scaffold can serve three distinct roles, reporter, effector, and chemosensitization adjuvant, with the operative role determined by cell-line phenotype and by which structural feature of the probe is engaged."]},{"key":"dc:title","label":"Title","values":["Exploring Fructose Mimetics as Chemotherapeutic Potentiators: Impact on GLUT5-Mediated Cancer Cell Vulnerability"]}]}],"canonical_facts":{"dc:contributor":["Marina Tanasova","Smitha Rao-Hatti"],"dc:contributor.committeemember":["Tarun Dam","Mark Tang","Robert Larson"],"dc:creator":["Buwa, Vedant"],"dc:date.created":["2026-01-01T08:00:00Z"],"dc:description.abstract":["Metabolic reprogramming toward increased sugar uptake is a hallmark of cancer, and fructose-specific uptake through the facilitative transporter GLUT5 is selectively upregulated in several adenocarcinomas, including breast and lung cancer. This dissertation develops and characterizes a panel of fluorescent fructose mimetics – the coumarin-based ManCou probes and the quinolinone-based ManQuin probes – as GLUT5-targeted reporters, cytotoxic effectors, and chemosensitization adjuvants, and establishes the boundaries within which each role holds. The central experimental strategy pairs each GLUT5-targeted glycoconjugate with its sugar-free aglycone control, isolating transporter-mediated cytotoxicity from cytotoxicity intrinsic to the fluorophore itself. In luminal (MCF7) and triple-negative (MDA-MB-231) breast carcinoma, the GLUT5-targeted ManCou conjugates produce durable, phenotype-scaled cytotoxicity that exceeds and outlasts that of the matched aglycones, while relatively sparing normal fibroblasts and defining a therapeutic window. The transport-restricting conjugate ManCou-Ph and the quinoline ManQuin-5 additionally sensitize triple-negative lines to the DNA-damaging agents oxaliplatin and cyclophosphamide at sub-cytotoxic concentrations, with the benefit confined to the sub-saturating dose range of each chemotherapeutic. In A549 lung adenocarcinoma, this relationship inverts: the GLUT5-targeted conjugates are inert across the tested concentration range, while the sugar-free aglycones – particularly the unsubstituted coumarin – produce marked, time-dependent cytotoxicity. This dissociation, further tested using the differently-selective ManQuin probes, identifies a tissue-level boundary on the conjugate-driven mechanism rather than a failure of GLUT5 routing, and reframes A549 cytotoxicity as intrinsic to the fluorophore rather than transporter-mediated. Across all phenotypes, the ManQuin probes maintain low intrinsic cytotoxicity through 72 hours of continuous exposure and impose no latent or post-washout toxicity, validating their use as non-perturbing reporters of GLUT5 activity independent of their role as effectors elsewhere in the panel. Together, these results establish a matched aglycone-conjugate framework for isolating GLUT5-mediated effects from off-target fluorophore activity and demonstrate that a single probe scaffold can serve three distinct roles, reporter, effector, and chemosensitization adjuvant, with the operative role determined by cell-line phenotype and by which structural feature of the probe is engaged."],"dc:identifier":["10.37099/mtu.dc.etdr/2130","https://digitalcommons.mtu.edu/etdr/2130"],"dc:subject":["Biochemistry"],"dc:title":["Exploring Fructose Mimetics as Chemotherapeutic Potentiators: Impact on GLUT5-Mediated Cancer Cell Vulnerability"],"thesis:degree_discipline":["Department of Chemistry"],"thesis:degree_level":["Open Access Dissertation"],"thesis:degree_name":["Doctor of Philosophy in Biochemistry and Molecular Biology (PhD)"]},"updated_at":"2026-11-19T08:19:32Z"}